NEWS FROM USA
NDA Approvals
|
Approval Date |
Drug |
NDA Sponsor |
Brand Name |
Prescribing information |
|
16 Nov 2018 |
Rifamycin Dr Tablets |
Cosmo Technologies |
Aemcolo |
|
|
20 Nov 2018 |
Emapalumab-Lzsg Injection |
Novimmune |
Gamifant |
ANDA Approvals
|
Approval Date |
Drug Product |
ANDA Sponsor |
Corresponding RLD |
Number Of Other Approved Generics |
|
19 Nov 2018 |
Actavis |
Abreva (GSk) |
None |
|
|
20 Nov 2018 |
Alembic |
Staxyn (Bayer) |
First approval for ODT |
|
|
20 Nov 2018 |
Elite Pharma |
Narco |
Four |
*Highlighted products are the 1st generics approval for the corresponding RLD
Tentative ANDA Approvals
|
Approval Date |
Drug |
Company |
|
16 Nov 2018 |
Deferasirox |
Zydus |
|
19 Nov 2018 |
Pregabalin |
Rising |
NEW GENERICS LAUNCHES IN US
|
DRUG |
COMPANY |
Corresponding RLD |
Annual sales quoted in press release as per IQVIA |
Press Release |
|
Tetrabenazine Tablets |
Lupin |
Xenazine (Valeant Pharmaceuticals) |
$153 Million |
OTHER NEWS FROM THE USA
Now, you can also follow us on twitter @pharmacaptions. If you have any query/suggestion then please write us at pharmacaption@gmail.com
No comments:
Post a Comment